Research / CCSI / Fundamental state Inspectable configuration
State dimensions Filing 0001866633-23-000040 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
878.22% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
11.10% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
66.24% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-1.32% · CORE · NOT_ENOUGH_HISTORY
Gross margin 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.gross_margin
81.39% · CORE · VALID
Operating margin 75th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.operating_margin
42.97% · CORE · VALID
R&D intensity 0th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.85% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.15% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 21 states Self-history eligible
Dec 31, 2021 0/7 normalized Level 3 Mar 31, 2022 0/7 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/8 normalized Level 3 Sep 30, 2022 0/7 normalized Amended as filed Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/8 normalized Level 3 Jun 30, 2023 0/8 normalized Level 3 Sep 30, 2023 3/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/8 normalized Level 3 Jun 30, 2024 7/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 856.57%
Current 878.22%
Delta 21.65% Capex Intensity Increased
Previous 10.91%
Current 11.10%
Delta 0.18% Cash Generation Increased
Previous 15.22%
Current 66.24%
Delta 51.02% Growth Decreased
Previous -0.40%
Current -1.32%
Delta -0.93% Margin Decreased
Previous 81.41%
Current 81.39%
Delta -0.02% Profitability Increased
Previous 41.86%
Current 42.97%
Delta 1.11% R And D Intensity Decreased
Previous 1.90%
Current 1.85%
Delta -0.05% Sbc Intensity Decreased
Previous 5.03%
Current 4.15%
Delta -0.88% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.